Tilak Mandadi - 31 Aug 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP, Chief Technology Officer
Signature
/s/ Tilak Mandadi
Issuer symbol
CVS
Transactions as of
31 Aug 2023
Net transactions value
-$850,664
Form type
4
Filing time
01 Sep 2023, 16:22:59 UTC
Previous filing
04 Apr 2023
Next filing
03 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability $850,664 -13,053 -39% $65.17 20,229 31 Aug 2023 Direct F1
holding CVS Common Stock (RSU) 66,565 31 Aug 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 96,496 31 Aug 2023 Common Stock 96,496 $74.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
F2 Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in three equal installments beginning 8/31/2023.
F3 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.